From Nasdaq:



The guru fundamental report for NOVARTIS AG (ADR) (NVS) shows that it rates highest using the Multi-Factor Investor model based on the strategy of Pim van Vliet. The stock is a large-cap growth stock in the Biotechnology & Drugs industry, with a rating of 87% based on the firm’s underlying fundamentals and the stock’s valuation. This rating indicates strong interest in the stock based on the strategy’s criteria.

Pim van Vliet, the head of Conservative Equities at Robeco Asset Management, has researched conservative factor investing, which led to the creation of this strategy and the publication of the book “High Returns From Low Risk: A Remarkable Stock Market Paradox”. Van Vliet’s strategy seeks low volatility stocks with strong momentum and high net payout yields. Validea, an investment research service, follows the published strategies of investment legends like Pim van Vliet, and offers stock analysis and model portfolios based on those strategies.

This news article summarizes the guru fundamental report for NOVARTIS AG (ADR) and highlights the strategy of Pim van Vliet, who has found that low volatility stocks can outperform their high volatility counterparts with less risk.



Read more: Validea Detailed Fundamental Analysis – NVS